Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001462808-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 15, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
277,593
Total Value
$26,443,743.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Exercise/Conversion | 52,500 | $42.45 | $2,228,625.00 | 344,376 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Exercise/Conversion | 40,031 | $40.74 | $1,630,862.94 | 384,407 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 800 | $198.55 | $158,840.16 | 383,607 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 11,833 | $200.11 | $2,367,954.88 | 371,774 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 13,368 | $200.78 | $2,683,985.60 | 358,406 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 21,447 | $201.75 | $4,326,947.26 | 336,959 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 18,869 | $203.06 | $3,831,550.46 | 318,090 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 17,949 | $203.87 | $3,659,309.30 | 300,141 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 4,995 | $204.84 | $1,023,189.29 | 295,146 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Common Stock | โ | Sep 11, 2026 | Sale | 3,270 | $205.81 | $672,990.53 | 291,876 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Stock Option (Right to Buy) | Derivative | Sep 11, 2026 | Exercise/Conversion | 52,500 | $42.45 | $2,228,625.00 | 0 | Direct | โ | View Details | |
Senior Advisor to the Chief Executive Officer | Stock Option (Right to Buy) | Derivative | Sep 11, 2026 | Exercise/Conversion | 40,031 | $40.74 | $1,630,862.94 | 88,069 | Direct | โ | View Details |